Table 1.
Clinical characteristics of the patients with HCC.
| Number | 103 |
|---|---|
| Age (years) | 68.1 ± 7.8 |
| Gender (M/F) | 79/24 |
|
| |
| Etiology | |
| (HBV/HCV/HBV + HCV/NBNC) | 15/65/2/21 |
|
| |
| Liver disease states | |
| (Chronic hepatitis/liver cirrhosis) | 57/46 |
|
| |
| Cancer cell differentiation | |
| (Well-/moderately/poorly differentiated) | 20/57/26 |
|
| |
| Paraclinical status | |
| Alb (g/dl) | 3.95 ± 0.44 |
| T-Bil (mg/dl) | 0.91 ± 0.58 |
| AST (IU/l) | 51.4 ± 41.8 |
| ALT (IU/l) | 44.9 ± 31.5 |
| GGT (IU/l) | 84.8 ± 96.9 |
| ALP (IU/l) | 317.3 ± 130.3 |
| LDH (IU/l) | 211.2 ± 71.4 |
| TC (mg/dl) | 168.9 ± 43.3 |
| TG (mg/dl) | 109.0 ± 56.6 |
| FBS (mg/dl) | 107.8 ± 42.9 |
Counts are presented as N; continuous data are presented as mean ± SD. Alb, albumin; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; TC, total cholesterol; TG, triglyceride; FBS, fasting blood sugar; HBV, hepatitis B virus; HCV, hepatitis C virus; NBNC, non-HBV and non-HCV.